Related Experiment Videos
Coronary artery surgery and myxoedema
S J Kirk1, H O O'Kane, P Morton
1Department of Cardiac Surgery, Royal Victoria Hospital, Belfast.
British Heart Journal
|December 1, 1987
Summary
Patients with coronary artery disease and myxedema (underactive thyroid) can safely undergo bypass surgery. Optimal management involves addressing coronary blockages before treating thyroid deficiency.
Area of Science:
- Cardiology
- Endocrinology
- Cardiothoracic Surgery
Background:
- Myxedema, a severe form of hypothyroidism, presents unique challenges in patients with coronary artery disease.
- Coronary artery bypass grafting (CABG) is a common treatment for severe coronary artery disease.
Observation:
- A patient diagnosed with myxedema underwent triple vessel CABG.
- The patient experienced an uneventful perioperative and postoperative recovery.
Findings:
- Surgical intervention for coronary artery disease is feasible in patients with myxedema.
- Successful management hinges on a staged approach to treatment.
Implications:
- This case highlights the importance of a multidisciplinary approach in managing complex cardiac patients.
- The findings suggest that optimizing myocardial blood flow before addressing thyroid dysfunction is a safe and effective strategy.